Navigation Links
Prostate Cancer and Bone Health

NEW YORK, June 22, 2012 /PRNewswire/ -- When weighing prostate cancer treatment options, potential side effects such as urinary control and sexual potency are the hot buttons. Seldom discussed, though significantly more damaging, is bone disease. Early diagnosis of prostate cancer, and the right treatment path, can drastically reduce a man's risk of developing prostate cancer-related bone disease.

(Photo: )

World renowned prostate surgery and robotic surgeon, Dr. David Samadi, pushes for comprehensive patient education, "Men are largely unaware of how prostate cancer can affect their bones."

As reported in the Bone Health In Focus Prostate Cancer report, which aims to increase awareness of prostate cancer-related bone disease, only one third of prostate cancer patients claim to have discussed bone health and the risk of bone metastases with their physician. Shocking for a secondary disease that can significantly impair quality of life and ultimately decrease survival by more than three years.

Prostate cancer-related bone disease results from either:

1)    Cancer Treatment-Induced Bone Loss (CTIBL)

"Seldom are men made aware of the damaging affects of androgen deprivation therapy (ADT) on their bones," says Dr. Samadi. "Hormone therapy for prostate cancer is proven to significantly decrease bone mass and cause bone weakening."

Also in the Bone Health In Focus Prostate Cancer report are statistics indicating less than half of men with non-metastatic prostate cancer were even aware that hormone therapy could damage their bones. One study found incidence of bone fracture in nearly one in five men within five years of beginning ADT.

"This lack of information can be seriously detrimental as a man weighs his prostate cancer treatment options," cautions Dr. Samadi. "Men who opt for hormone therapy may be further jeopardizing their health and their power to fight prostate cancer. Robotic prostatectomy surgery removes the cancerous prostate and significantly reduces the risk of metastases."

2)    Bone Metastases

Prostate cancer is an unpredictable disease and can spread quickly, without warning and without symptoms. Men who skip their annual PSA blood test are putting themselves at risk for late-stage diagnosis. Others may be diagnosed early, but choose not to treat their prostate cancer, opting instead for watchful waiting.

"Delaying diagnosis or treatment of prostate cancer opens the door to bone disease and unnecessarily exposes men to another life-threatening condition," cautions Dr. Samadi. Bone disease skeletal-related events (SREs) such as fracture or spinal cord injury are serious alone, but they can also interfere with a man's prostate cancer treatment.

"Unfortunately, many men are unaware that late-stage diagnosis of prostate cancer has implications beyond the cancer itself," Dr. Samadi explains. "Prostate cancer-related bone disease is further evidence of the irresponsible nature of the U.S. government task force's recommendation against the PSA test."

Roughly 75 percent of men diagnosed with an advanced form of prostate cancer will develop bone metastases.

"Men don't have to fear bone disease, but they do have to be knowledgeable about it," says Dr. Samadi. "It is not inevitable. Early diagnosis beginning with the PSA test and swift treatment through robotic prostate removal surgery can help eliminate prostate cancer long before the bones are affected."

Dr. David Samadi is Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center, and creator of the SMART (Samadi Modified Advanced Robotic Technique) robotic prostatectomy surgery.

Related Links:


Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
2. Breakthrough Prostate Cancer Diagnostics
3. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
4. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
7. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
8. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
9. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
10. New Candidate Drug Stops Cancer Cells, Regenerates Nerve Cells
11. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
Post Your Comments:
(Date:11/30/2015)... Nuance Communications, Inc. (NASDAQ: NUAN ) and ... today jointly announced a new integrated set of clinical ... College of Radiology,s (ACR) Imaging 3.0™ tools to enable ... current and emerging value-based payment models . ... clinical decision support, radiology reporting and image sharing technology ...
(Date:11/30/2015)... HYDERABAD, India , Nov. 30, 2015 Varian Medical ... (MoU) to develop an educational partnership with Apollo Hospitals Group, the ... a program that will help train radiation technologists in the country. ... executive officer of Apollo Knowledge, and Ashok Kakkar , Varian,s ... . India , Varian intends ...
(Date:11/30/2015)... Belgium , Nov. 30, 2015   VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... present at the LD Micro Conference, which will be held ... Attending from VolitionRx will be David Kratochvil ... , Vice President of Investor Relations. ® ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two ... American children and adults, according to a new study by researchers at the School ... in Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers ...
(Date:11/30/2015)... ... 30, 2015 , ... The recently published 32nd Annual Report ... reveals that in 2014, someone called a poison center about every 11 seconds. ... were human exposure cases. , The American Association of Poison Control Centers (AAPCC) ...
(Date:11/30/2015)... PA (PRWEB) , ... November 30, 2015 , ... ... Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties products ... markets in the US, effective immediately. , “We are pleased to announce ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announced at the Radiology Society of North America (RSNA) annual meeting, being held ... 60% growth from 2014. Throughout 2015, the company has completed installations for ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Kreithen”), one of the leading plastic surgery practices in Florida, is proud to ... to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. ...
Breaking Medicine News(10 mins):